Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Immunitybio Inc (IBRX)

Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Analysts Predict Strong Growth for Cancer Vaccine Market: Key Biotech Stocks to Consider BayStreet.ca - Wed Sep 4, 11:39AM CDT

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Back in 2022, Nature published...

BIOV.CN : 0.0500 (unch)
BVAXF : 0.0365 (-0.82%)
BNTX : 117.35 (-0.86%)
CVAC : 2.87 (-1.37%)
VXRT : 0.8039 (+1.58%)
IBRX : 3.32 (+2.76%)
ImmunityBio: Q2 Earnings Snapshot AP - Mon Aug 12, 7:11AM CDT

ImmunityBio: Q2 Earnings Snapshot

IBRX : 3.32 (+2.76%)
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 Newswire.ca - Wed May 1, 9:05AM CDT

/CNW/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of...

BIOV.CN : 0.0500 (unch)
BVAXF : 0.0365 (-0.82%)
MRNA : 56.75 (-0.14%)
BOLD : 2.93 (+1.03%)
IBRX : 3.32 (+2.76%)
MGNX : 3.73 (-0.27%)
Promising Outlook as Biotech Sector Advances Cancer Treatments Amidst Rising Diagnoses BayStreet.ca - Wed May 1, 8:54AM CDT

USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer Society...

BRX : 26.81 (-1.18%)
BIOV.CN : 0.0500 (unch)
BVAXF : 0.0365 (-0.82%)
MRNA : 56.75 (-0.14%)
BOLD : 2.93 (+1.03%)
IBRX : 3.32 (+2.76%)
MGNX : 3.73 (-0.27%)
Biotech Sector Advances in Pancreatic Cancer Research BayStreet.ca - Thu Mar 14, 8:42AM CDT

USA News Group – Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate of all major cancers today. However, researchers and the biotech sector are working...

BRX : 26.81 (-1.18%)
ONCY : 1.2295 (-0.85%)
ONC.TO : 1.70 (-6.08%)
NVS : 115.14 (+0.29%)
IBRX : 3.32 (+2.76%)
ACRS : 1.1600 (-0.85%)
NUVB : 2.07 (+2.99%)
Biotech’s Role in Addressing the Pancreatic Cancer Emergency FinancialNewsMedia - Thu Mar 14, 7:45AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END

NVX : 2.40 (unch)
ONCY : 1.2295 (-0.85%)
ONC.TO : 1.70 (-6.08%)
NVS : 115.14 (+0.29%)
IBRX : 3.32 (+2.76%)
ACRS : 1.1600 (-0.85%)
NUVB : 2.07 (+2.99%)
Should You Still Buy the Nasdaq's Best-Performing October Stocks? Motley Fool - Fri Nov 3, 2023

Last month's big winners were tricky to handle due to the amount of speculation investors were willing to do with them.

COMP : 5.62 (unch)
GPCR : 38.86 (-3.55%)
IBRX : 3.32 (+2.76%)
OLK : 26.08 (+0.31%)
Why Shares of ImmunityBio Jumped This Week Motley Fool - Fri Sep 15, 2023

The company's founder is spending his own money to help finance the business's efforts.

IBRX : 3.32 (+2.76%)
SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 29, 2023 in the Class Action Filed on Behalf of ImmunityBio, Inc. (IBRX) Shareholders PR Newswire - Mon Aug 28, 2023

/PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ImmunityBio, Inc. (NASDAQ: IBRX)...

IBRX : 3.32 (+2.76%)
SHAREHOLDER ALERT: Levi & Korsinsky Notifies ImmunityBio, Inc.(IBRX) Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire - Thu Aug 24, 2023

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ImmunityBio, Inc. ("ImmunityBio" or the "Company") (NASDAQ: IBRX) of a class action securities...

IBRX : 3.32 (+2.76%)

Barchart Exclusives

Has Hamilton Lane Run Out of Steam? Barchart - 50 minutes ago
Summary Hamilton Lane's strong technical indicators and recent price appreciation. The firm's diversified investment strategies and global presence. Impressive financial performance and growth projections. Mixed analyst ratings and investor sentiment. The Chart of the Day belongs to the asset management firm Hamilton Lane (HLNE) . I found the stock by... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot